BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu B, Zhai Y, Ji M, Wei Y, Wu J, Xue W, Tao WW, Wu H. Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice. Front Pharmacol 2020;11:570555. [PMID: 33101028 DOI: 10.3389/fphar.2020.570555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo Z, Ali Q, Abaidullah M, Gao Z, Diao X, Liu B, Wang Z, Zhu X, Cui Y, Li D, Shi Y. High fat diet-induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiota. Appl Microbiol Biotechnol 2022. [PMID: 36173452 DOI: 10.1007/s00253-022-12203-7] [Reference Citation Analysis]
2 Zhou P, Kang JL, Cheng QQ, Chen MT, Xie Y, Zhou H. Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxide. Phytomedicine 2022;104:154305. [PMID: 35792446 DOI: 10.1016/j.phymed.2022.154305] [Reference Citation Analysis]
3 Liu X, Bao Y, Lin Z, Tang L, Mao P. Platelets inhibit development of atherosclerosis in atherosclerotic mice. Cell Cycle 2022;:1-11. [PMID: 35213268 DOI: 10.1080/15384101.2022.2044703] [Reference Citation Analysis]
4 Wang B, Qiu J, Lian J, Yang X, Zhou J. Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy. Front Cardiovasc Med 2021;8:723886. [PMID: 34888358 DOI: 10.3389/fcvm.2021.723886] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Shi X, Huang H, Zhou M, Liu Y, Wu H, Dai M. Paeonol Attenuated Vascular Fibrosis Through Regulating Treg/Th17 Balance in a Gut Microbiota-Dependent Manner. Front Pharmacol 2021;12:765482. [PMID: 34880759 DOI: 10.3389/fphar.2021.765482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Li X, Hong J, Wang Y, Pei M, Wang L, Gong Z. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD. Front Mol Biosci 2021;8:733507. [PMID: 34660695 DOI: 10.3389/fmolb.2021.733507] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Karlsen TR, Kong XY, Holm S, Quiles-Jiménez A, Dahl TB, Yang K, Sagen EL, Skarpengland T, S Øgaard JD, Holm K, Vestad B, Olsen MB, Aukrust P, Bjørås M, Hov JR, Halvorsen B, Gregersen I. NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype. Sci Rep 2021;11:19749. [PMID: 34611194 DOI: 10.1038/s41598-021-98820-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Saeedi Saravi SS, Bonetti NR, Pugin B, Constancias F, Pasterk L, Gobbato S, Akhmedov A, Liberale L, Lüscher TF, Camici GG, Beer JH. Lifelong dietary omega-3 fatty acid suppresses thrombotic potential through gut microbiota alteration in aged mice. iScience 2021;24:102897. [PMID: 34401676 DOI: 10.1016/j.isci.2021.102897] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Li Y, Ji X, Wu H, Li X, Zhang H, Tang D. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism. J Ethnopharmacol 2021;278:114207. [PMID: 34000365 DOI: 10.1016/j.jep.2021.114207] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Liu L, Zou Z, Yang J, Li X, Zhu B, Zhang H, Sun Y, Zhang Y, Zhang ZJ, Wang W. Jianpi Jieyu Decoction, An Empirical Herbal Formula, Exerts Psychotropic Effects in Association With Modulation of Gut Microbial Diversity and GABA Activity. Front Pharmacol 2021;12:645638. [PMID: 33935741 DOI: 10.3389/fphar.2021.645638] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Huang L, Wang J, Xu R, Liu Y, Liu Z. Regulatory effect of traditional Chinese medicine on gut microbiota in patients with atherosclerosis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23730. [PMID: 33327364 DOI: 10.1097/MD.0000000000023730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]